Skip to content
10-Q

Quarterly Report

ImmunoGen, Inc.

0001558370-23-017411

← back to feed
Filed
Nov 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 25, 2023 266.26M sh
Shares Diluted Q3 2023 · Sep 30, 2023 287.59M sh
Shares Diluted Q3 2023 · Sep 30, 2023 265.27M sh
Shares Diluted Q3 2023 · Sep 30, 2022 253.51M sh
Shares Diluted Q3 2023 · Sep 30, 2022 253.37M sh
Capex Q3 2023 · Sep 30, 2023 $1.64M
Capex Q3 2023 · Sep 30, 2022 $1.12M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$137.69M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$169.6M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $605.54M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $275.14M
Stockholders Equity Q3 2023 · Sep 30, 2023 $561.6M
Stockholders Equity Q3 2023 · Jun 30, 2023 $490.84M
Stockholders Equity Q3 2023 · Mar 31, 2023 $121.92M
Stockholders Equity Q3 2023 · Dec 31, 2022 $155.83M
Stockholders Equity Q3 2023 · Sep 30, 2022 $178.01M
Stockholders Equity Q3 2023 · Jun 30, 2022 $249.83M
Stockholders Equity Q3 2023 · Mar 31, 2022 $306.47M
Stockholders Equity Q3 2023 · Dec 31, 2021 $325.59M
Current Liabilities Q3 2023 · Sep 30, 2023 $134.66M
Current Liabilities Q3 2023 · Dec 31, 2022 $121.86M
Total Liabilities Q3 2023 · Sep 30, 2023 $260.51M
Total Liabilities Q3 2023 · Dec 31, 2022 $193.11M
Current Assets Q3 2023 · Sep 30, 2023 $766.9M
Current Assets Q3 2023 · Dec 31, 2022 $304.12M
Total Assets Q3 2023 · Sep 30, 2023 $822.1M
Total Assets Q3 2023 · Dec 31, 2022 $348.94M
Eps Diluted Q3 2023 · Sep 30, 2023 $0.10
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.05
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.31
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.65
Eps Basic Q3 2023 · Sep 30, 2023 $0.10
Eps Basic Q3 2023 · Sep 30, 2023 −$0.05
Eps Basic Q3 2023 · Sep 30, 2022 −$0.31
Eps Basic Q3 2023 · Sep 30, 2022 −$0.65
Sga Expense Q3 2023 · Sep 30, 2023 $37.74M
Sga Expense Q3 2023 · Sep 30, 2023 $114.12M
Sga Expense Q3 2023 · Sep 30, 2022 $33.62M
Sga Expense Q3 2023 · Sep 30, 2022 $74.06M
Rd Expense Q3 2023 · Sep 30, 2023 $47.57M
Rd Expense Q3 2023 · Sep 30, 2023 $149.27M
Rd Expense Q3 2023 · Sep 30, 2022 $59.18M
Rd Expense Q3 2023 · Sep 30, 2022 $154.89M
Net Income Q3 2023 · Sep 30, 2023 $30.75M
Net Income Q3 2023 · Sep 30, 2023 −$14.51M
Net Income Q3 2023 · Jun 30, 2023 −$4.25M
Net Income Q3 2023 · Mar 31, 2023 −$41.01M
Net Income Q3 2023 · Dec 31, 2022 −$59.01M
Net Income Q3 2023 · Sep 30, 2022 −$77.76M
Net Income Q3 2023 · Sep 30, 2022 −$163.92M
Net Income Q3 2023 · Jun 30, 2022 −$62.02M
Net Income Q3 2023 · Mar 31, 2022 −$24.15M
Operating Income Q3 2023 · Sep 30, 2023 $25.96M
Operating Income Q3 2023 · Sep 30, 2023 −$20.63M
Operating Income Q3 2023 · Sep 30, 2022 −$77.43M
Operating Income Q3 2023 · Sep 30, 2022 −$161.33M